Zogenix, Inc. (ZGNX) CEO Dr. Stephen Farr on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/05/21
Zogenix (ZGNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 10/28/21
Zogenix's Fintepla Shows Long-Term Seizure Frequency Reductions In Childhood EpilepsyBenzinga • 09/30/21
New FINTEPLA® (Fenfluramine) Data Show Long-Term Seizure Frequency Reductions in Patients with Lennox-Gastaut Syndrome (LGS)GlobeNewsWire • 09/30/21
Zogenix, Inc. (ZGNX) CEO Dr. Stephen Farr on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/06/21
Zogenix Provides Corporate Update and Reports Second Quarter 2021 Financial ResultsGlobeNewsWire • 08/05/21
VIP Siblings and www.vipsibling.com, New Resources to Support Brothers & Sisters of Those Living with Severe, Rare Epilepsies, Now Available from Zogenix and 10 Advocacy GroupsGlobeNewsWire • 07/14/21